Singapore is projected to experience a 7% compound annual growth rate in the sales of meat substitutes from 2022 to 2027, becoming a leading innovation hub for alternative proteins in the Asia-Pacific region, particularly in the ASEAN market. The soy-based product category will continue to lead in value, but single-cell protein categories will see the fastest growth. This shift is driven by government initiatives, high household income, and openness to innovative food concepts. In 2022, meat substitute sales grew by 56.5% year-on-year, with hotel, restaurant, and café introductions of meat substitute dishes. The government's efforts in developing adjacent alternative protein spaces and approving commercial sales of cultured meat are expected to further impact the domestic meat substitute market.